Stay updated on LY3471851 in Eczema: Clinical Trial
Sign up to get notified when there's something new on the LY3471851 in Eczema: Clinical Trial page.

Latest updates to the LY3471851 in Eczema: Clinical Trial page
- CheckyesterdayChange DetectedLocations sections by state were added, listing sites in Arkansas, California, Florida, Georgia, Indiana, Kentucky, Michigan, New Hampshire, Ohio, Oklahoma, Pennsylvania, and Texas, along with a new Revision: v3.3.3 tag. The prior state-location blocks from v3.3.2 were removed.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a PubMed-based note indicating that publications are automatically filled from PubMed and may not all relate to the study, and updated the revision to v3.3.2 (replacing the previous PubMed note and revision v3.2.0).SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the government funding and operating status notice that was previously displayed on the page, which is an administrative detail and does not affect study information or participation details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedPage layout and UI appear to have minor updates; core study content, eligibility criteria, locations, and outcome measures remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference5%

- Check88 days agoChange DetectedPage update adds version v3.1.0 and removes several substantive drug-safety topics and a prior version note.SummaryDifference0.7%

Stay in the know with updates to LY3471851 in Eczema: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3471851 in Eczema: Clinical Trial page.